BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31547977)

  • 21. EG-VEGF silencing inhibits cell proliferation and promotes cell apoptosis in pancreatic carcinoma via PI3K/AKT/mTOR signaling pathway.
    Yan X; Hui Y; Hua Y; Huang L; Wang L; Peng F; Tang C; Liu D; Song J; Wang F
    Biomed Pharmacother; 2019 Jan; 109():762-769. PubMed ID: 30551529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ACK1 promotes hepatocellular carcinoma progression via downregulating WWOX and activating AKT signaling.
    Xie B; Zen Q; Wang X; He X; Xie Y; Zhang Z; Li H
    Int J Oncol; 2015 May; 46(5):2057-66. PubMed ID: 25738261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and clinical significance of STIP1 in papillary thyroid carcinoma.
    Yuan MH; Zhou RS; She B; Xu HF; Wang JY; Wei LX
    Tumour Biol; 2014 Mar; 35(3):2391-5. PubMed ID: 24163084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor stress-induced phosphoprotein1 (STIP1) as a prognostic biomarker in ovarian cancer.
    Chao A; Lai CH; Tsai CL; Hsueh S; Hsueh C; Lin CY; Chou HH; Lin YJ; Chen HW; Chang TC; Wang TH
    PLoS One; 2013; 8(2):e57084. PubMed ID: 23468915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of PPM1H on malignant phenotype of human pancreatic cancer cells.
    Zhu H; Qin H; Li DM; Liu J; Zhao Q
    Oncol Rep; 2016 Nov; 36(5):2926-2934. PubMed ID: 27599670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The stem cell factor/c-kit receptor pathway enhances proliferation and invasion of pancreatic cancer cells.
    Yasuda A; Sawai H; Takahashi H; Ochi N; Matsuo Y; Funahashi H; Sato M; Okada Y; Takeyama H; Manabe T
    Mol Cancer; 2006 Oct; 5():46. PubMed ID: 17044945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silencing profilin-1 inhibits gastric cancer progression via integrin β1/focal adhesion kinase pathway modulation.
    Cheng YJ; Zhu ZX; Zhou JS; Hu ZQ; Zhang JP; Cai QP; Wang LH
    World J Gastroenterol; 2015 Feb; 21(8):2323-35. PubMed ID: 25741138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased expression of MUC1 induces apoptosis and inhibits migration in pancreatic cancer PANC-1 cells via regulation of Slug pathway.
    Zhao P; Meng M; Xu B; Dong A; Ni G; Lu L
    Cancer Biomark; 2017 Dec; 20(4):469-476. PubMed ID: 28869438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CXCL1 from tumor-associated lymphatic endothelial cells drives gastric cancer cell into lymphatic system via activating integrin β1/FAK/AKT signaling.
    Wang Z; Wang Z; Li G; Wu H; Sun K; Chen J; Feng Y; Chen C; Cai S; Xu J; He Y
    Cancer Lett; 2017 Jan; 385():28-38. PubMed ID: 27832972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth-stimulatory activity of TIMP-2 is mediated through c-Src activation followed by activation of FAK, PI3-kinase/AKT, and ERK1/2 independent of MMP inhibition in lung adenocarcinoma cells.
    Kim HIe; Lee HS; Kim TH; Lee JS; Lee ST; Lee SJ
    Oncotarget; 2015 Dec; 6(40):42905-22. PubMed ID: 26556867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of the Epidermal Growth Factor-like Domain 7 and Inhibition of Migration and Epithelial-Mesenchymal Transition in Human Pancreatic Cancer PANC-1 Cells.
    Wang YL; Dong FL; Yang J; Li Z; Zhi QM; Zhao X; Yang Y; Li DC; Shen XC; Zhou J
    Asian Pac J Cancer Prev; 2015; 16(9):4065-9. PubMed ID: 25987088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plumbagin induces cell cycle arrest and autophagy and suppresses epithelial to mesenchymal transition involving PI3K/Akt/mTOR-mediated pathway in human pancreatic cancer cells.
    Wang F; Wang Q; Zhou ZW; Yu SN; Pan ST; He ZX; Zhang X; Wang D; Yang YX; Yang T; Sun T; Li M; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():537-60. PubMed ID: 25632222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of KLF9 in pancreatic cancer and its effects on the invasion, migration, apoptosis, cell cycle distribution, and proliferation of pancreatic cancer cell lines.
    Zhong Z; Zhou F; Wang D; Wu M; Zhou W; Zou Y; Li J; Wu L; Yin X
    Oncol Rep; 2018 Dec; 40(6):3852-3860. PubMed ID: 30542730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of the PI3K/Akt pathway mediates bone morphogenetic protein 2-induced invasion of pancreatic cancer cells Panc-1.
    Chen X; Liao J; Lu Y; Duan X; Sun W
    Pathol Oncol Res; 2011 Jun; 17(2):257-61. PubMed ID: 20848249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2-Methoxy-4-vinylphenol Attenuates Migration of Human Pancreatic Cancer Cells
    Kim DH; Han SI; Go B; Oh UH; Kim CS; Jung YH; Lee J; Kim JH
    Anticancer Res; 2019 Dec; 39(12):6685-6691. PubMed ID: 31810933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
    Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
    BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. JAK2-Mediated Phosphorylation of Stress-Induced Phosphoprotein-1 (STIP1) in Human Cells.
    Chao A; Liao MJ; Chen SH; Lee YS; Tsai CN; Lin CY; Tsai CL
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthetic 8-hydroxydeoxyguanosine inhibited metastasis of pancreatic cancer through concerted inhibitions of ERM and Rho-GTPase.
    Park JM; Han YM; Jeong M; Chung MH; Kwon CI; Ko KH; Hahm KB
    Free Radic Biol Med; 2017 Sep; 110():151-161. PubMed ID: 28602912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kctd20 promotes the development of non-small cell lung cancer through activating Fak/AKT pathway and predicts poor overall survival of patients.
    Zhang X; Zhou H; Cai L; Fan C; Liu Y; Wang L; Li Q; Miao Y
    Mol Carcinog; 2017 Sep; 56(9):2058-2065. PubMed ID: 28398603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stress-induced phosphoprotein-1 maintains the stability of JAK2 in cancer cells.
    Tsai CL; Chao A; Jung SM; Tsai CN; Lin CY; Chen SH; Sue SC; Wang TH; Wang HS; Lai CH
    Oncotarget; 2016 Aug; 7(31):50548-50563. PubMed ID: 27409672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.